Search research articles
Contact Us
Filters
Showing results (111-120 of 140) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice
Domenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 26, 2026
Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen
Tiffany Y Sia, Sally Kraiem, Kendal Rosalik, et al.
Gynecologic Oncology
|
May 28, 2023
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
Eric Rios-Doria, Amir Momeni-Boroujeni, Claire F Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2023
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
Scientific Reports
|
October 21, 2020
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
Harini Veeraraghavan, Claire F Friedman, Deborah F DeLair, et al.
Gynecologic Oncology
|
November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
Marina Stasenko, Irina Tunnage, Charles W Ashley, et al.
JCO Precision Oncology
|
January 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases
Judy J Wang, Juliet Milani, Sarah Kane, et al.
Gynecologic Oncology
|
February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer
Arnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 140) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice
Domenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 26, 2026
Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen
Tiffany Y Sia, Sally Kraiem, Kendal Rosalik, et al.
Gynecologic Oncology
|
May 28, 2023
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
Eric Rios-Doria, Amir Momeni-Boroujeni, Claire F Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2023
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez, et al.
Scientific Reports
|
October 21, 2020
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
Harini Veeraraghavan, Claire F Friedman, Deborah F DeLair, et al.
Gynecologic Oncology
|
November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
Marina Stasenko, Irina Tunnage, Charles W Ashley, et al.
JCO Precision Oncology
|
January 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases
Judy J Wang, Juliet Milani, Sarah Kane, et al.
Gynecologic Oncology
|
February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer
Arnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.
Page
of 14